Suspected cholestatic liver injury induced by favipiravir in a patient with COVID-19

Favipiravir is an antiviral drug that is expected to have a therapeutic effect on SARS-CoV2 infection. Teratogenicity and hyperuricemia are known as the main side effects of favipiravir, but little is known about other side effects. This report describes a case of cholestatic liver injury induced by...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamazaki, Shingo, Suzuki, Takaaki, Sayama, Misa, Nakada, Taka-aki, Igari, Hidetoshi, Ishii, Itsuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833994/
https://www.ncbi.nlm.nih.gov/pubmed/33402301
http://dx.doi.org/10.1016/j.jiac.2020.12.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833994/
https://www.ncbi.nlm.nih.gov/pubmed/33402301
http://dx.doi.org/10.1016/j.jiac.2020.12.021

Ejemplares similares